Chapuis B, Louis J, Barrelet L, Dialdas J, Dragon V, Cerottini J C
Schweiz Med Wochenschr. 1980 May 24;110(21):796-801.
Circulating immune complexes (CIC) have been studied in one or several serum samples obtained from 249 patients with cancer. 42.4% of patients with evolutive tumors and 26.9% of patients in complete remission have elevated levels of CIC. It appears that, in approximately one case out of 3, the presence of CIC is not necessarily in relationship with the tumor, but could be the consequence of other clinical factors. In some instances, repeated plasmapheresis results in decreased CIC levels. The specificity of the antibodies present in CIC is not yet known.
已对从249例癌症患者获得的一份或几份血清样本中的循环免疫复合物（CIC）进行了研究。进展期肿瘤患者中有42.4%、完全缓解期患者中有26.9%的CIC水平升高。似乎大约每3例中就有1例，CIC的存在不一定与肿瘤相关，而可能是其他临床因素的结果。在某些情况下，重复进行血浆置换会导致CIC水平降低。CIC中存在的抗体的特异性尚不清楚。
